Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: Part I - Methods

Urology

Volumn 56, Issue 6, 2000, Pages 972-980

  Ackerman, Stacey J ^a   Rein, Alison L ^a   Blute, Michael ^b   Beusterien, Kathleen ^a   Sullivan, Erin M ^a   Tanio, Craig P ^c   Manyak, Michael J ^d   Strauss, Michael J ^a  

^a Health Economics and Outcomes Research   (United States)

^b MAYO CLINIC   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; PROBABILITY; PROSTATE HYPERTROPHY; REMISSION; RETREATMENT; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

ADRENERGIC ALPHA-ANTAGONISTS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEALTH CARE COSTS; HEAT; HUMANS; MALE; MARKOV CHAINS; MICROWAVES; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0033674254     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00828-1     Document Type: Article

References (30)

1. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia
2. Watchful waiting vs immediate transurethral resection for symptomatic prostatism: The importance of patients' preferences
3. Benign prostatic hyperplasia: Medical and minimally invasive treatment options
4. Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia
5. U.S. IDE multicenter study results of a new high temperature office based microwave system (T3) for the treatment of BPH
6. Preferential heating using transurethral microwave thermoablation (T3) improves clinical results
7. Durability of results with transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia (BPH) using the Targis(TM) (T3) System
8. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus α-blocker treatment of patients with benign prostatic hyperplasia
9. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: Part II- Results
10. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies
11. The Hytrin Community Assessment Trial: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia
12. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response
13. The International Terazosin Trial: A multicenter study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia
14. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
15. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate
16. The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism
17. Transurethral resection of the prostate for benign prostatic hyperplasia - A local review
18. The Oxford laser prostate trial: A double-blind randomized controlled trial of contact vaporization of the prostate against transurethral resection; preliminary results
19. Deaths and complications following prostatectomy in 1400 men in the northern region of England
20. Prostatectomy: Patients' perception and long-term follow-up
21. Two year follow-up of a prospective randomized trial of electrovaporization versus resection of prostate
22. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia
23. Incorporating risk attitude into Markov-process decision models: Importance for individual decision making